Adding Antithrombotic to tPA Does Not Improve Stroke Outcome 🔗 Access full article via Medscape NeurologyArgatroban and eptifibatide were ineffective as adjunctive therapies to thrombolysis in patients with ischemic stroke in the MOST trial. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
